Apoptosis and autoimmunity: [from mechanisms to treatments] 🔍
edited by Martin Herrmann and J.R Kalden
Wiley-Blackwell, Weinheim, United States, 2003
英语 [en] · PDF · 19.3MB · 2003 · 📗 未知类型的图书 · 🚀/ia · Save
描述
this Is The First Comprehensive Book About The Relationship Between Apoptosis And Autoimmune Diseases. It Offers A Unique Up-to-date Overview On Research Results On The Defective Execution Of Apoptosis And The Incomplete Clearance Of Apoptotic Cells. The Molecular And Cellular Mechanisms Involved Are Described In Detail. As A Possible Consequence Of Apoptotic Dysfunction, The Development Of Severe Autoimmune Diseases (e.g., Rheumatoid Arthritis, Systemic Lupus Erythematosus) Is Discussed. An Outlook On Future Research Topics Includes The Evaluation Of Novel Therapeutic Strategies.
备选作者
Herrmann, M. (Martin), Dr; Kalden, J. R. (Joachim Robert)
备选作者
M Herrmann, Dr.; J R Kalden
备选作者
[name missing]
备用出版商
Weinheim: Wiley-VCH
备用出版商
Wiley-VCH GmbH
备用版本
Weinheim, England, 2003
备用版本
Germany, Germany
备用版本
Weinheim, Ü2004
备用版本
March 21, 2003
备用版本
1st, 2003
元数据中的注释
obscured text on back cover
元数据中的注释
Subtitle from cover
Includes bibliographical references and index
Includes bibliographical references and index
备用描述
Part 1. General feature of apoptosis.
Part 1. General feature of apoptosis. -- Keith Elkon
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.]
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen -- Carlos A. Casiano ... [et al.]
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen -- Carlos A. Casiano ... [et al.] -- Alessandra Amendola and Mauro Piacentini
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen -- Carlos A. Casiano ... [et al.] -- Alessandra Amendola and Mauro Piacentini -- Paul J. Utz -- Part 6. The role of DNA binding proteins for systemic autoimmunity.
Part 1. General feature of apoptosis.-- Keith Elkon-- Saquib Lakhani, Binfeng Lu and Richard A. Flavell-- Part 2. Clearance of apoptotic cells.-- Reinhard E. Voll ... [et al.]-- Dror Mevorach-- Patrizia Rovere-Querini-- Véronique Rigot and Giovanna Chimini-- Christopher D. Gregory and Andrew Devitt-- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells.-- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer-- Hanns-Martin Lorenz-- Yuji Yamanishi amd Gary S. Firestein-- Thomas D. Beyer ... [et al.]-- Part 4. Immunogenicity of apoptotic cells.-- Lars Jenne and Birthe Sauter-- Angelo A. Manfredi-- Part 5. "Altered self" in dying cells.-- Antony Rosen and Livia Casciola-Rosen-- Carlos A. Casiano ... [et al.]-- Alessandra Amendola and Mauro Piacentini-- Paul J. Utz-- Part 6. The role of DNA binding proteins for systemic autoimmunity.-- Keith Jürgen W.C. Dieker, Johan van der Vlag and Jo H.M. Berden
Part 1. General feature of apoptosis. -- Keith Elkon
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.]
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells.
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen -- Carlos A. Casiano ... [et al.]
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen -- Carlos A. Casiano ... [et al.] -- Alessandra Amendola and Mauro Piacentini
Part 1. General feature of apoptosis. -- Keith Elkon -- Saquib Lakhani, Binfeng Lu and Richard A. Flavell -- Part 2. Clearance of apoptotic cells. -- Reinhard E. Voll ... [et al.] -- Dror Mevorach -- Patrizia Rovere-Querini -- Véronique Rigot and Giovanna Chimini -- Christopher D. Gregory and Andrew Devitt -- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells. -- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer -- Hanns-Martin Lorenz -- Yuji Yamanishi amd Gary S. Firestein -- Thomas D. Beyer ... [et al.] -- Part 4. Immunogenicity of apoptotic cells. -- Lars Jenne and Birthe Sauter -- Angelo A. Manfredi -- Part 5. "Altered self" in dying cells. -- Antony Rosen and Livia Casciola-Rosen -- Carlos A. Casiano ... [et al.] -- Alessandra Amendola and Mauro Piacentini -- Paul J. Utz -- Part 6. The role of DNA binding proteins for systemic autoimmunity.
Part 1. General feature of apoptosis.-- Keith Elkon-- Saquib Lakhani, Binfeng Lu and Richard A. Flavell-- Part 2. Clearance of apoptotic cells.-- Reinhard E. Voll ... [et al.]-- Dror Mevorach-- Patrizia Rovere-Querini-- Véronique Rigot and Giovanna Chimini-- Christopher D. Gregory and Andrew Devitt-- Part 3. Autoimmunity caused by defective execution of apoptosis or defective clearance of apoptosis cells.-- Frédérik Rieux-Laucat, Franc̲oise le Deist and Alain Fischer-- Hanns-Martin Lorenz-- Yuji Yamanishi amd Gary S. Firestein-- Thomas D. Beyer ... [et al.]-- Part 4. Immunogenicity of apoptotic cells.-- Lars Jenne and Birthe Sauter-- Angelo A. Manfredi-- Part 5. "Altered self" in dying cells.-- Antony Rosen and Livia Casciola-Rosen-- Carlos A. Casiano ... [et al.]-- Alessandra Amendola and Mauro Piacentini-- Paul J. Utz-- Part 6. The role of DNA binding proteins for systemic autoimmunity.-- Keith Jürgen W.C. Dieker, Johan van der Vlag and Jo H.M. Berden
备用描述
Apoptosis and autoimmunity are "hot topics" in cell biology and immunology and interrelations between the two phenomena are reflected in an increasing amount of primary literature. Animal models and clinical observations indicate that the defective execution of apoptosis or defective clearance of apoptotic cells may cause severe dysfunctions, resulting in such autoimmune diseases as rheumatoid arthritis and lupus erythematosus. This is the first book to provide a concise insight into the molecular and cellular mechanisms of regular and misdirected apoptosis as well as its implications for the development of autoimmune diseases. Researchers and clinicians alike will appreciate the perspectives on new strategies in diagnostics and therapy. The text is rounded off by a glossary explaining over 200 related terms, many of them precisely defined here for the first time
备用描述
xxi, 381 p. : 25 cm
Subtitle from cover
Includes bibliographical references and index
Subtitle from cover
Includes bibliographical references and index
开源日期
2023-06-28
🚀 快速下载
成为会员以支持书籍、论文等的长期保存。为了感谢您对我们的支持，您将获得高速下载权益。❤️
如果您在本月捐款，您将获得双倍的快速下载次数。
🐢 低速下载
由可信的合作方提供。 更多信息请参见常见问题解答。 （可能需要验证浏览器——无限次下载！）
- 低速服务器（合作方提供） #1 （稍快但需要排队）
- 低速服务器（合作方提供） #2 （稍快但需要排队）
- 低速服务器（合作方提供） #3 （稍快但需要排队）
- 低速服务器（合作方提供） #4 （稍快但需要排队）
- 低速服务器（合作方提供） #5 （无需排队，但可能非常慢）
- 低速服务器（合作方提供） #6 （无需排队，但可能非常慢）
- 低速服务器（合作方提供） #7 （无需排队，但可能非常慢）
- 低速服务器（合作方提供） #8 （无需排队，但可能非常慢）
- 低速服务器（合作方提供） #9 （无需排队，但可能非常慢）
- 下载后： 在我们的查看器中打开
所有选项下载的文件都相同，应该可以安全使用。即使这样，从互联网下载文件时始终要小心。例如，确保您的设备更新及时。
外部下载
-
对于大文件，我们建议使用下载管理器以防止中断。
推荐的下载管理器：JDownloader -
您将需要一个电子书或 PDF 阅读器来打开文件，具体取决于文件格式。
推荐的电子书阅读器：Anna的档案在线查看器、ReadEra和Calibre -
使用在线工具进行格式转换。
推荐的转换工具：CloudConvert和PrintFriendly -
您可以将 PDF 和 EPUB 文件发送到您的 Kindle 或 Kobo 电子阅读器。
推荐的工具：亚马逊的“发送到 Kindle”和djazz 的“发送到 Kobo/Kindle” -
支持作者和图书馆
✍️ 如果您喜欢这个并且能够负担得起，请考虑购买原版，或直接支持作者。
📚 如果您当地的图书馆有这本书，请考虑在那里免费借阅。
下面的文字仅以英文继续。
总下载量：
“文件的MD5”是根据文件内容计算出的哈希值，并且基于该内容具有相当的唯一性。我们这里索引的所有影子图书馆都主要使用MD5来标识文件。
一个文件可能会出现在多个影子图书馆中。有关我们编译的各种数据集的信息，请参见数据集页面。
有关此文件的详细信息，请查看其JSON 文件。 Live/debug JSON version. Live/debug page.